AU2008201345A1 - Method of producing a dry earthworm powder - Google Patents
Method of producing a dry earthworm powder Download PDFInfo
- Publication number
- AU2008201345A1 AU2008201345A1 AU2008201345A AU2008201345A AU2008201345A1 AU 2008201345 A1 AU2008201345 A1 AU 2008201345A1 AU 2008201345 A AU2008201345 A AU 2008201345A AU 2008201345 A AU2008201345 A AU 2008201345A AU 2008201345 A1 AU2008201345 A1 AU 2008201345A1
- Authority
- AU
- Australia
- Prior art keywords
- earthworms
- acid
- living
- homogenate
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000361919 Metaphire sieboldi Species 0.000 title claims description 42
- 239000000843 powder Substances 0.000 title claims description 30
- 238000000034 method Methods 0.000 title claims description 27
- 241001233061 earthworms Species 0.000 claims description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 150000007524 organic acids Chemical class 0.000 claims description 16
- 238000004108 freeze drying Methods 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 6
- 230000008014 freezing Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000007872 degassing Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 239000003929 acidic solution Substances 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 239000001384 succinic acid Substances 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 19
- 229910021529 ammonia Inorganic materials 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 13
- 230000029142 excretion Effects 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 230000009471 action Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 230000003313 weakening effect Effects 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 241000237636 Pheretima Species 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 108010088842 Fibrinolysin Proteins 0.000 description 3
- 241001495098 Lumbricus rubellus Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229910052785 arsenic Inorganic materials 0.000 description 3
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 229940012957 plasmin Drugs 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241000243662 Lumbricus terrestris Species 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000000422 nocturnal effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 241001262938 Allolobophora Species 0.000 description 1
- 241000243818 Annelida Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000357261 Dendrobaena octaedra Species 0.000 description 1
- 241000985366 Drawida hattamimizu Species 0.000 description 1
- 241000243686 Eisenia fetida Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 101000605403 Homo sapiens Plasminogen Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 241001478739 Ledebouria socialis Species 0.000 description 1
- 241001290772 Limnodrilus Species 0.000 description 1
- JCYZMTMYPZHVBF-UHFFFAOYSA-N Melarsoprol Chemical compound NC1=NC(N)=NC(NC=2C=CC(=CC=2)[As]2SC(CO)CS2)=N1 JCYZMTMYPZHVBF-UHFFFAOYSA-N 0.000 description 1
- 241000361908 Metaphire hilgendorfi Species 0.000 description 1
- 241001277610 Oligochaeta <Asteraceae> Species 0.000 description 1
- 241000881741 Pontodrilus Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000243653 Tubifex Species 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000410 anti-febrile effect Effects 0.000 description 1
- 239000002488 antieczema agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000003296 parturifacient Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
AUSTRALIA Patents Act 1990 COMPLETE SPECIFICATION Standard Patent Applicant(s): Well Stone Co. Invention Title: Method of producing a dry earthworm powder The following statement is a full description of this invention, including the best method for performing it known to me/us: P77341 AU PaSetFmng Appibcation 2008-3-25.doc (M) - 2 METHOD OF PRODUCING A DRY EARTHWORM POWDER The present invention relates to a method of producing a dry earthworm powder effective in treatment of 5 various diseases, by removing the dirt in digestive tracts and on the skin of the earthworms without deterioration in the pharmacological action inherent to the earthworms. Earthworms have been used from ancient times in oriental countries as drugs for prevention and treatment 10 of various diseases, and have found applications such as intracystic calculus-contraction and releasing-stimulating agent, anti-choloplania agent, parturifacient, tonic, hair growth tonic, pickup, antifebrile, spasm-treating agent, blood flow accelerator, hemiplegia-treating agent, 15 indirect analgesic, urination improving agent, anti bronchial asthma agent, anti-hypertension agent and others. It is necessary to remove the digest of an earthworm remaining in the digestive tracts, the dirt on the skin, 20 and others for production of a medicine for oral administration by using the living body of the earthworm as the raw material, and various methods for that purpose have been proposed. Examples thereof so far proposed include methods of 25 producing a dry earthworm powder useful as an anti diabetes agent, anti-hyperlipidemia agent, or blood pressure-adjusting agent, by immersing living bodies of earthworms in an aqueous solution of an alkali salt such as sodium salt or potassium salt, allowing them to excrete 30 the cast in the digestive tracts, wet-grinding the earthworms, and freeze-drying the suspension thus obtained under vacuum (JP1-47718A, JP1-47719A, JP1-47720A and JP1 268639A), and a method of producing a medicine for N:\Melbourne\Cases\Patent\77000-77999\P7734I.AL\Specis\P7734l.AU GHSPECI.doc 25/03/08 - 3 patients with thrombosis, by immersing living bodies of earthworms in an aqueous acid solution kept at 6 to 26 0 C for 0.1 to 5 hours, allowing them to excrete the cast in the digestive tracts, grinding the earthworms, degassing 5 the homogenate, and vacuum-drying the homogenate, while the temperature is raised stepwise (JP3-72427A). However, immersion of living bodies of earthworms in an aqueous alkali salt or acid solution for an extended period of time leads to weakening of the earthworms, 10 consequently to denaturation of the proteins contained in the body, deterioration in enzyme activities and also in the pharmacological action of the earthworm powder obtained. An object of the present invention is to provide a 15 method of producing a dry earthworm powder in the state having a favorably pharmacological action, by allowing living bodies of earthworms to excrete the digest remaining in the digestive tracts and the dirt on the skin efficiently without weakening the earthworms. 20 After intensive studies to make living bodies of earthworms excrete the digest remaining in the digestive tracts effectively without weakening the earthworms, the inventors have found that, if living earthworms are placed under light, then brought into contact with an organic 25 acid, an environment unfavorable for the earthworms, before processing, and grown under the condition for a particular time, the earthworms excrete the digest in the digestive tracts and cover themselves with the excretion to cope with the environment, and thus, that it was 30 possible to obtain purified living bodies of the earthworms by removing the dirt or the excretion on the skin, and made the present invention, based on the finding. N:\Melbourne\Cases\Patent\77000-77999\P7734I.AU\Specia\P7734l.AU GHSPECI.doc 25103/08 - 4 Thus, the present invention provides a method of producing a dry earthworm powder which comprises the steps of: standing living earthworms under light for 10 to 50 hours, removing the dirt formed on the skin thereof, 5 adding an organic acid to the living earthworms, diluting the acid rapidly with addition of water, adjusting the pH of the aqueous acidic solution to 2 to 5, standing the earthworm mixture for 3 to 180 minutes under the pH condition, washing the earthworms with water, grinding the 10 earthworms into a homogenate, freezing the homogenate at 18 0 C to -35 0 C, keeping the frozen homogenate for 20 to 240 hours, and freeze-drying and degassing the frozen homogenate under vacuum simultaneously. Hereinafter, the method according to the present 15 invention will be described in detail. In the method according to the present invention, a living earthworm is used as the raw material, and the living earthworm used is arbitrarily selected from organisms belonging to Annelida Oligochaeta, generally 20 called earthworms, such as Lumbricus rubellus, Lumbricus terrestris, Eisenia foetida, Allolobophora caliginosa, Dendrobaena octaedra, Allolobophora japonica Michaelsen, Drawida hattamimizu Hatai, Pheretima divergens Michaelsen, Pheretima communissima, Pheretima agrestis, Pheretima 25 sieboldi Horst, Pheretima hilgendorfi, Pontodrilus matsushimensis Iizuka, Tubifex hattai Nomura, Limnodrilus gotoi Hatai or L. Socialis Stephenson and so on. In the method according to the present invention, first, living earthworms are placed under light for a 30 particular period. Specifically, living earthworms withdrawn from a worm bed are placed in a tray-shaped flat box and kept there for 10 to 50 hours under sunlight or under illumination at night. The internal capacity of the N:\Melbourne\Cases\Patent\77000-77999\P7734 I.AU\Specis\P77341.AU GHSPECI.doc 25/03/08 - 5 flat box then is an amount corresponding to a thickness of about 30 to 60 mm, preferably 40 to 50 mm. When placed under light, the earthworms, which are nocturnal, try to protect themselves by covering the skin with dirt for 5 blockage of light or prevention from water vaporization, and repeated removal of the dirt by a suitable means several times finally prompts the earthworms to release solid matter and body fluid out of the enteric tracts and cover the skin therewith. Then in the flat box, the 10 multiple living earthworms stacked on each other try to crawl deeper below other earthworms, looking for a darker place while in contact with each other, which in turn leads to separation of the dirt and the excretion on the skin by friction. If the living earthworms are enclosed 15 for example with a nonwoven fabric, the dirt and the excretion separated by friction can be adsorbed and removed easily. In the method according to the present invention, the living earthworms, from which the dirt and the 20 excretion are removed, are then washed with water, and brought into an living environment unpleasant to the living earthworms by the addition of an organic acid. The addition of the organic acid may be carried out by scattering an organic acid powder as it is or a 25 concentrated aqueous organic acid solution on the living earthworms. Examples of the organic acid used then include acetic acid, malic acid, citric acid, lactic acid, malonic acid, succinic acid, and the like. These acids may be 30 used alone or as a mixture of two or more acids. The particularly favorable organic acid is citric acid. In such a case, prolonged contact between the living earthworms and an organic acid powder or a conc. aqueous N:\Melbourne\Cases\Patent\77000-77999\P77341.AU\Specis\P77341.AU GHSPECI.doc 25/03/08 - 6 organic acid solution leads to death or weakening of the earthworms and thus to no excretion of the digest in the digestive tracts, and therefore, the living earthworms are preferably washed with water as soon as possible after 5 contact with the organic acid, normally within 30 seconds or less, preferably 20 seconds or less, until the pH of the earthworms becomes in the range of 2 to 5. The dilution with water should be carried out promptly. Sufficient care should be given to the fact that the delay 10 may lead to death of the earthworms. Thus in the method according to the present invention, it is possible to ensure sterilization action by once sterilizing living earthworms by using the sterilization action of an organic acid and then 15 sterilizing them further by freeze drying under vacuum. In the method according to the present invention, because the earthworms are placed under light, i.e. a living environment unfavorable for activity of the nocturnal living earthworm, and additionally brought into 20 an living environment extremely unpleasant to the living earthworms, the living earthworms release solid and liquid matters of the dirt and the excretion for protection of themselves and for improvement of the living environment to purify themselves automatically. 25 Use of an organic acid, which has a sterilizing action, in the method according to the present invention leads to excretion of the digests remaining in the digestive organs as described above and sterilization of the unwanted bacteria that are not removed simply by water 30 washing. Presence of water is indispensable for the self protecting function, but about 65% of the living earthworm structure is water, and thus, there is some periodical N:\Melbourne\Cases\Patent\77000-77999\P77341.AU\Specis\P77341.AU GHSPECIdoc 25/03/08 - 7 allowance for the self-protecting function. However, because death of the living earthworms is undesirable, care should be given to the control of the period during which the living earthworms are placed under an unpleasant 5 living environment. The period may vary according to the condition used, but normally in the range of 3 to 180 minutes. As described above, when living earthworms are brought into an unpleasant living environment by the 10 addition of an organic acid, the digest remaining in the digestive tracts, ammonia, a cause for foul odor, and arsenic-containing body fluid that is toxic to the body are excreted, and most of ammonia is removed by the acid. Conventionally, cleaned living earthworms were 15 pulverized and frozen as they were, leaving ammonia unremoved, and the ammonia was removed in the following freeze drying step under vacuum, but the removal of ammonia was insufficient and fluctuating, making product quality control more difficult. In addition, because 20 ammonia is removed in the freeze drying step under vacuum, the apparatuses in the step are damaged more easily, demanding frequent maintenance and thus, increasing the running cost and making the system less attractive economically. Further, ammonia had a problem in 25 difficulty of product quality control, because the ammonia content of living earthworm varies seasonally and ammonia may cause gastritis when it remains even in a small amount. In the method according to the present invention, most ammonia is removed before freeze drying under vacuum 30 and ammonia remaining in a small amount is also removed completely by freeze drying under vacuum, advantageously giving a uniform-quality product. Then, the living bodies of the earthworms after N:\Melbourne\Cases\Patent\77000-77999\P7734 1.AU\Specis\P7734 LAU GHSPEC.doc 25/03/08 - 8 practically complete removal of the dirt are washed with purified water and then ground into liquid or paste-like homogenate. The grinding is carried out, for example, in a homogenizer, blender, homomixer, mashing machine, or 5 high-pressure cell mill, normally at a temperature of 1 to 25*C or, preferably, 2 to 15*C. The homogenate is then placed and dried in a stainless steel tray. Since the enzymes contained in the living body of the earthworm are inactive when the cells are still alive, but react 10 instantaneously with dead cells to generate heat and strong foul odor by putrefaction, for prevention thereof, it is required to use freeze-drying under vacuum process in which the homogenate can be cooled rapidly to a temperature of -18 0 C to -35*C and the enzyme activities 15 are restricted. For pulverization without deterioration in the pharmacological action inherent to the earthworm, the homogenate should be frozen rapidly, but, on the other hand, freezing in an excessively short period of time or 20 extremely rapid freezing is also unfavorable, because impurities present together with proteins which are principal components of the earthworm paste may form spotty unfrozen regions and may not be separated. For that reason, the freezing is performed favorably at a low 25 temperature of -180C to -35*C over a period of 20 to 240 hours, preferably 50 to 170 hours. During freeze drying under vacuum, it is important to select a condition allowing favorable removal of water as well as impurities. For that purpose, it is 30 advantageous to perform freeze drying under vacuum by increasing the temperature stepwise in the range of -60C to +90C under a pressure of 50 Pa or less taking 10 to 60 hours. N:\Melbourne\Cases\Patent\77000-77999\P7734 I.AU\Specis\P7734 1AU GHSPECI.doc 25/03/08 -9 For example as described above, the homogenate is frozen at a temperature of -180C to -35*C over a period of 20 to 240 hours and freeze drying under vacuum is performed for 10 to 60 hours by changing a temperature and 5 a pressure stepwise in the range of -60*C to +90*C and 4 to 80 Pa, respectively, to obtain a pale yellow dry earthworm powder in the sterile state. The deaeration then is performed by vacuum aspiration. In the method according to the present invention, it 10 is possible to shorten the freeze-drying period, which traditionally took 100 hours or more, significantly by selecting the drying condition as described above. The dry earthworm powder thus obtained contains arginine in an amount of 70 to 120 mg, lysine of 110 to 15 150 mg, histidine of 35 to 60 mg, phenylalanine of 55 to 80 mg, tyrosine of 50 to 75 mg, leucine of 100 to 150 mg, isoleucine of 60 to 90 mg, methionine of 25 to 40 mg, valine of 70 to 105 mg, alanine of 85 to 135 mg, glycine of 75 to 105 mg, proline of 60 to 85 mg, glutamic acid of 20 210 to 300 mg, serine of 80 to 110 mg, threonine of 75 to 110 mg, aspartic acid of 150 to 220 mg, tryptophan of 15 to 30 mg and cystine of 20 to 35 mg in 100 g of the powder, although the composition may vary slightly according to the kind of the earthworm used and the 25 sampling site and period. Industrial Applicability According to the method of the present invention, it is possible to remove the dirt or the excretion of living earthworms by using their natural behavior without any 30 man-made action and also to obtain favorable dry earthworm powder containing no microbe or a foul odor such as of ammonia and containing only a limited amount of arsenic. In addition, the dry earthworm powder obtained by the N:\Melbourne\Cases\Patent\77000-77999\P7734I.AU\Specis\P7734I.AU GHSPECI.doc 25103108 - 10 method according to the present invention contains enzymes at activities of about 1.2 to 1.5 times higher than those of the powder obtained by conventional methods, and shows higher permeability into cells. 5 Similarly to dry earthworm powders prepared by conventional methods, the dry earthworm powder prepared by the method according to the present invention is useful as a blood pressure-adjusting agent, an anti-hyperlipidemia agent, an anti-diabetes agent, a thrombolytic agent or the 10 like. Active ingredients separated from the dry earthworm powder may be used in applications such as whitener, anti wrinkling agent, anti-eczema agent, and athlete's foot treating agent. Hereinafter, the best modes of carrying out the 15 present invention will be described. Example 1 30 kg of living earthworms of Lumbricus rubellus were placed and spread to a thickness of approximately 5 20 cm in a flat box and exposed to fluorescent lamp irradiation for 24 hours; the living earthworms were covered with a nonwoven fabric, allowing adsorption of the dirt and the excretion accumulated on the skin with the nonwoven fabric, and then washed with water. 25 Subsequently, 250 g of citric acid powder was scattered uniformly thereon, and after 15 seconds, the earthworm mixture was diluted with 30 liter of purified water. The pH immediately after addition of water was 2.25, while the pH at the end of dilution was 2.74. 30 Then, the earthworms immersed in the diluted citric acid was left still at 20 0 C for 60 minutes, when the earthworms, to modify the living environment unpleasant to themselves, excrete the body fluid and the digest in the N:\Meibourne\Cases\Patent\77000-77999\P7734I.AU\Specis\P77341.AU GHSPECI.doc 25/03/08 - 11 digestive tracts out of the body as well as ammonia, a cause of foul odor, and arsenic, a compound hazardous to the body. Conventionally, it was required to immerse 5 earthworms in an aqueous citric acid solution at pH 3 to 6 for at least one hour, resulting in weakening of the earthworms and increase in loss thereof, but brief contact with high-concentration citric acid resulted in almost complete elimination of ammonia without weakening of the 10 earthworms. The living earthworms were then separated from the dirty aqueous citrate solution, washed with water, and ground into an earthworm paste at 10 0 C by using a homogenizer. Then, the earthworm paste was placed in a 15 stainless steel tray, cooled instantaneously to -30 0 C, and kept at the same temperature, allowing gradual freezing over a period of 50 hours. The freeze drying under vacuum was performed in such a manner that the earthworm paste thus frozen was kept 20 standing at a temperature of -35*C under gradually reduced pressure down to 50 Pa taking 3 hours, and the frozen earthworm paste was heated stepwise at a temperature of 20 0 C under a pressure of 40 Pa for 12 hours, at a temperature of 40 0 C under a pressure of 35 Pa for 25 25 hours, and finally at a temperature of 80 0 C under a pressure of 20 Pa for 5 hours. The processing gave a pale yellow dry earthworm powder having a water content of 8 % by mass. The amino acid contents of the dry powder thus obtained are shown in Table 1. 30 Example 2 A pale yellow dry earthworm powder was obtained in a similar manner to Example 1, except that 30 kg of the N:\Melbourne\Cases\Patent\77000-77999\P7734 .AU\Specis\P7734 I AU GHSPECIdoc 25/03/08 - 12 earthworms of Lumbricus rubellus in Example 1 were replaced with 30 kg of those of Lumbricus terrestris. The amino acid contents of the dry powders thus obtained are shown in Table 1. 5 T a b 1 e 1 AMINO ACID CONTENT (unit: mg/100g) Example Example 1 Example 2 Arginine 114 72.5 Lysine 148 128 Histidine 55 40 Phenylalanin 77 62.5 e Tyrosine 73 57 Leucine 145 119.5 Isoleucine 87 74 Methionine 35 33 Valine 104 89 Alanine 131 98 Glycine 103 82.5 Proline 83 65.5 Glutamic 296 245.5 acid Serine 105 87 Threonine 104 81.5 Aspartic 212 167 acid Tryptophan 28 20 Cystine 32 21.5 N:\Melbourne\Cases\Patent\77000-77999\P7734I.AU\Specis\P77341.AU GHSPECI.doc 25/03/08 - 13 Example 3 A dark yellow dry earthworm powder in a composition similar to that of the powder obtained in Examplel was 5 obtained in a similar manner to Example 1, except that 250 g of citric acid was replaced with 160 g of succinic acid. Reference Example The dry earthworm powder obtained in Example 1 was 10 processed by the method described in the Example of JP2716472B, to give a purified protease. To 0.5 pg of the purified protease, added was purified human plasminogen (manufactured by KABIAB, 0.05 CU) for reaction, and the plasmin activity after the 15 reaction was determined. Subsequently, the plasmin hydrolytic activity, as determined from the difference between when the purified protease was added and not added, was 0.145 nmol/minute. The plasmin hydrolytic activity, as determined for comparison similarly by using 20 the purified protease prepared from the dry earthworm powder according to the conventional method described in the patent publication described above, was 0.112 nmol/minute, indicating that the enzyme activity derived from the dry earthworm powder prepared by the method 25 according to the present invention was approximately 1.3 times higher. In the claims which follow and in the preceding description of the invention, except where the context requires otherwise due to express language or necessary 30 implication, the word "comprise" or variations such as "comprises" or "comprising" is used in an inclusive sense, i.e. to specify the presence of the stated features but not to preclude the presence or addition of further N:\Melbourne\Cases\Patent\77000-77999\P7734 I.AU\Specis\P7734t.AU GHSPECI.doc 25/03/08 - 14 features in various embodiments of the invention. It is to be understood that, if any prior art publication is referred to herein, such reference does not constitute an admission that the publication forms a part 5 of the common general knowledge in the art, in Australia or any other country. N:\Melbounie\Cases\Patent\77000-77999\P7734I.AU\Specis\P7734 .AU GHSPECI.doc 25/03/08
Claims (2)
1. A method of producing a dry earthworm powder which comprises the steps of: standing living earthworms under 5 light for 10 to 50 hours, removing the dirt formed on the skin thereof, adding an organic acid to the living earthworms, diluting the acid rapidly with addition of water, adjusting the pH of the aqueous acidic solution to 2 to 5, standing the earthworm mixture for 3 to 180 10 minutes under the pH condition, washing the earthworms with water, grinding the earthworms into a homogenate, freezing the homogenate at -18 0 C to -35 0 C, keeping the frozen homogenate for 20 to 240 hours, and freeze-drying and degassing the frozen homogenate under vacuum 15 simultaneously.
2. The method of producing a dry earthworm powder according to Claim 1, wherein the organic acid is an organic acid selected from acetic acid, malic acid, citric 20 acid, lactic acid, malonic acid, and succinic acid. N:\Melbourne\Cases\Patent\77000-77999\P77341.AU\Specis\P77341.AU GHSPECI.doc 25/03/08
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008201345A AU2008201345B2 (en) | 2008-03-25 | 2008-03-25 | Method of producing a dry earthworm powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008201345A AU2008201345B2 (en) | 2008-03-25 | 2008-03-25 | Method of producing a dry earthworm powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2008201345A1 true AU2008201345A1 (en) | 2009-10-15 |
| AU2008201345B2 AU2008201345B2 (en) | 2009-12-24 |
Family
ID=41165722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008201345A Active AU2008201345B2 (en) | 2008-03-25 | 2008-03-25 | Method of producing a dry earthworm powder |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2008201345B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010029453A1 (en) * | 2008-09-10 | 2010-03-18 | Pt.Dexa Medica | Composition of thrombolytic agent and anti thrombosis and also its production method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5024844A (en) * | 1987-08-18 | 1991-06-18 | Eimei Company, Ltd. | Process for the production of dried earthworm powder and antihyperlipemic, antidiabetic, antihypertensive and antihypotensive preparations containing dried earthworm powder as active ingredient |
-
2008
- 2008-03-25 AU AU2008201345A patent/AU2008201345B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5024844A (en) * | 1987-08-18 | 1991-06-18 | Eimei Company, Ltd. | Process for the production of dried earthworm powder and antihyperlipemic, antidiabetic, antihypertensive and antihypotensive preparations containing dried earthworm powder as active ingredient |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010029453A1 (en) * | 2008-09-10 | 2010-03-18 | Pt.Dexa Medica | Composition of thrombolytic agent and anti thrombosis and also its production method |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008201345B2 (en) | 2009-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8137701B2 (en) | Method of producing a dry earthworm powder | |
| RU2543318C2 (en) | Method of producing dry earthworm powder | |
| AU2010226962B2 (en) | Method of producing a dry earthworm powder | |
| TWI330532B (en) | Method of producing a dry earthworm powder | |
| CN101543512B (en) | Production method of earthworm dry powder | |
| EP2105139B1 (en) | Method of producing a dry earthworm powder | |
| JP2009249362A (en) | Method for producing detoxified dried earthworm powder | |
| AU2008201345B2 (en) | Method of producing a dry earthworm powder | |
| JP6409151B1 (en) | Method for producing oral composition and oral composition | |
| CA2627031C (en) | Method of producing a dry earthworm powder | |
| KR100977113B1 (en) | Manufacturing method of earthworm dry powder | |
| KR101198192B1 (en) | Method for producing dry earthworm powder | |
| AU2022200329B2 (en) | Amyloid beta fibril decomposing agent, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by amyloid beta fibril formation | |
| HK1131908B (en) | Method of producing a dry earthworm powder | |
| JP6566600B2 (en) | Method for producing skin injury therapeutic agent and skin injury therapeutic agent | |
| JP2018154606A (en) | Production method of hypotensive agent, and hypotensive agent | |
| JPWO2018173971A1 (en) | Method for producing nasal drop composition, and nasal drop composition | |
| JP6913342B2 (en) | Manufacturing method of blood sugar level rise inhibitor and blood sugar level rise inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PRIORITY DETAILS TO DELETE JP2006-266579, 29 SEPT 2006 JP |
|
| FGA | Letters patent sealed or granted (standard patent) |